Ercros (ECR) - Net Assets

Latest as of December 2025: €298.23 Million EUR ≈ $348.66 Million USD

Based on the latest financial reports, Ercros (ECR) has net assets worth €298.23 Million EUR (≈ $348.66 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€694.30 Million ≈ $811.71 Million USD) and total liabilities (€396.07 Million ≈ $463.05 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Ercros liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets €298.23 Million
% of Total Assets 42.95%
Annual Growth Rate -15.75%
5-Year Change -10.07%
10-Year Change 35.66%
Growth Volatility 42.38

Ercros - Net Assets Trend (2000–2025)

This chart illustrates how Ercros's net assets have evolved over time, based on quarterly financial data. Also explore ECR total assets for the complete picture of this company's asset base.

Annual Net Assets for Ercros (2000–2025)

The table below shows the annual net assets of Ercros from 2000 to 2025. For live valuation and market cap data, see ECR market cap overview.

Year Net Assets Change
2025-12-31 €298.23 Million
≈ $348.66 Million
-12.58%
2024-12-31 €341.16 Million
≈ $398.85 Million
-6.05%
2023-12-31 €363.12 Million
≈ $424.52 Million
+0.67%
2022-12-31 €360.71 Million
≈ $421.71 Million
+8.77%
2021-12-31 €331.61 Million
≈ $387.69 Million
+16.68%
2020-12-31 €284.21 Million
≈ $332.28 Million
-2.69%
2019-12-31 €292.08 Million
≈ $341.48 Million
+7.12%
2018-12-31 €272.67 Million
≈ $318.78 Million
+10.17%
2017-12-31 €247.49 Million
≈ $289.34 Million
+12.58%
2016-12-31 €219.83 Million
≈ $257.00 Million
+24.99%
2015-12-31 €175.88 Million
≈ $205.62 Million
+4.57%
2014-12-31 €168.19 Million
≈ $196.63 Million
-2.33%
2013-12-31 €172.21 Million
≈ $201.33 Million
-0.95%
2012-12-31 €173.87 Million
≈ $203.27 Million
-7.08%
2011-12-31 €187.11 Million
≈ $218.75 Million
-2.66%
2010-12-31 €192.23 Million
≈ $224.74 Million
-6.40%
2009-12-31 €205.38 Million
≈ $240.11 Million
-20.15%
2008-12-31 €257.20 Million
≈ $300.69 Million
-44.47%
2007-12-31 €463.14 Million
≈ $541.46 Million
+28.66%
2006-12-31 €359.97 Million
≈ $420.84 Million
+41.79%
2005-12-31 €253.87 Million
≈ $296.80 Million
+167.06%
2004-12-31 €95.06 Million
≈ $111.14 Million
-25.62%
2003-12-31 €127.80 Million
≈ $149.41 Million
-12.22%
2002-12-31 €145.59 Million
≈ $170.21 Million
+4.99%
2001-12-31 €138.67 Million
≈ $162.12 Million
-99.36%
2000-12-31 €21.67 Billion
≈ $25.33 Billion
--

Equity Component Analysis

This analysis shows how different components contribute to Ercros's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 118.2% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock €27.43 Million 9.55%
Other Comprehensive Income €259.82 Million 90.45%
Other Components €53.59 Million 18.65%
Total Equity €287.25 Million 100.00%

Ercros Competitors by Market Cap

The table below lists competitors of Ercros ranked by their market capitalization.

Company Market Cap
SES AI Corp
NYSE:SES
$315.51 Million
Primis Financial Corp
NASDAQ:FRST
$315.61 Million
Médica Sur S.A.B. de C.V
MX:MEDICAB
$315.62 Million
DITTO (THAILAND)
BK:DITTO-R
$315.78 Million
Teraplast Bist
RO:TRP
$315.31 Million
Taiwan Chinsan Electronic Industrial Co Ltd
TWO:8042
$315.29 Million
Sichuan Tianwei Electronic Co Ltd
SHG:688511
$315.24 Million
BenQ Materials Corp
TW:8215
$315.21 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ercros's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 341,157,000 to 287,247,000, a change of -53,910,000 (-15.8%).
  • Net loss of 53,585,000 reduced equity.
  • Dividend payments of 325,000 reduced retained earnings.
  • Other comprehensive income decreased equity by 65,567,000.
  • Other factors increased equity by 65,567,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €-53.59 Million -18.65%
Dividends Paid €325.00K -0.11%
Other Comprehensive Income €-65.57 Million -22.83%
Other Changes €65.57 Million +22.83%
Total Change €- -15.80%

Book Value vs Market Value Analysis

This analysis compares Ercros's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.08x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.63x to 1.08x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-12-31 €5.40 €3.40 x
2004-12-31 €4.03 €3.40 x
2005-12-31 €4.25 €3.40 x
2006-12-31 €4.95 €3.40 x
2007-12-31 €5.29 €3.40 x
2008-12-31 €2.92 €3.40 x
2009-12-31 €2.04 €3.40 x
2010-12-31 €1.91 €3.40 x
2011-12-31 €1.86 €3.40 x
2012-12-31 €1.73 €3.40 x
2013-12-31 €1.66 €3.40 x
2014-12-31 €1.53 €3.40 x
2015-12-31 €1.54 €3.40 x
2016-12-31 €1.93 €3.40 x
2017-12-31 €2.20 €3.40 x
2018-12-31 €2.50 €3.40 x
2019-12-31 €2.75 €3.40 x
2020-12-31 €2.77 €3.40 x
2021-12-31 €3.36 €3.40 x
2022-12-31 €3.83 €3.40 x
2023-12-31 €3.88 €3.40 x
2024-12-31 €3.73 €3.40 x
2025-12-31 €3.14 €3.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ercros utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -18.65%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -8.55%
  • • Asset Turnover: 0.90x
  • • Equity Multiplier: 2.42x
  • Recent ROE (-18.65%) is above the historical average (-33.77%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2003 -14.08% -8.32% 0.61x 2.80x €-30.43 Million
2004 -33.64% -14.97% 0.58x 3.84x €-41.10 Million
2005 15.47% 8.90% 0.57x 3.06x €13.62 Million
2006 1.36% 0.67% 0.72x 2.82x €-30.75 Million
2007 -710.14% -387.85% 0.89x 2.06x €-3.32 Billion
2008 -79.73% -23.43% 1.23x 2.78x €-228.48 Million
2009 -24.12% -8.68% 0.89x 3.12x €-69.99 Million
2010 -6.46% -2.03% 0.97x 3.27x €-31.56 Million
2011 -0.43% -0.12% 1.13x 3.24x €-19.48 Million
2012 -6.98% -1.90% 1.06x 3.48x €-29.52 Million
2013 -2.18% -0.60% 1.11x 3.28x €-20.97 Million
2014 -3.74% -1.04% 1.16x 3.10x €-23.11 Million
2015 4.12% 1.17% 1.21x 2.91x €-10.35 Million
2016 20.54% 7.49% 1.08x 2.55x €23.18 Million
2017 18.01% 6.50% 1.14x 2.42x €19.83 Million
2018 16.46% 6.68% 1.11x 2.22x €17.61 Million
2019 10.63% 4.63% 1.02x 2.25x €1.83 Million
2020 2.20% 1.10% 0.96x 2.08x €-22.16 Million
2021 13.06% 5.61% 1.09x 2.14x €10.14 Million
2022 17.46% 6.31% 1.34x 2.07x €26.92 Million
2023 7.60% 3.80% 1.06x 1.88x €-8.73 Million
2024 -3.42% -1.75% 0.95x 2.05x €-45.77 Million
2025 -18.65% -8.55% 0.90x 2.42x €-82.31 Million

Industry Comparison

This section compares Ercros's net assets metrics with peer companies in the Chemicals industry.

No peer company data available for comparison.

About Ercros

MC:ECR Spain Chemicals
Market Cap
$363.45 Million
€310.88 Million EUR
Market Cap Rank
#14764 Global
#92 in Spain
Share Price
€3.40
Change (1 day)
-0.15%
52-Week Range
€2.24 - €3.47
All Time High
€4.83
About

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, caustic potash, caustic soda, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, … Read more